Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$246K Buy
14,286
+47
+0.3% +$801 0.02% 265
2021
Q3
$238K Sell
14,239
-504
-3% -$7.54K 0.02% 235
2021
Q2
$198K Sell
14,743
-109
-0.7% -$1.36K 0.02% 382
2021
Q1
$177K Buy
+14,852
New +$180K 0.02% 394
2020
Q3
Sell
-10,094
Closed -$141K 324
2020
Q2
$141K Sell
10,094
-14,714
-59% -$200K 0.01% 322
2020
Q1
$292K Buy
24,808
+1,656
+7% +$21.9K 0.03% 381
2019
Q4
$328K Buy
23,152
+2,772
+14% +$34K 0.03% 406
2019
Q3
$215K Buy
20,380
+8,953
+78% +$107K 0.02% 434
2019
Q2
$166K Buy
11,427
+439
+4% +$6.22K 0.02% 421
2019
Q1
$154K Sell
10,988
-3,544
-24% -$57.4K 0.02% 429
2018
Q4
$254K Sell
14,532
-172
-1% -$2.79K 0.03% 374
2018
Q3
$224K Buy
+14,704
New +$212K 0.02% 392

Other funds holding INVA

6 Meridian's INVA Position: Q4 2021 in Review

6 Meridian increased its Innoviva (INVA) stake by 0.33% in Q4 2021, buying an estimated $801 and bringing the position to 14,286 shares worth $246K. The position accounts for 0.02% of the portfolio, ranked #265.

6 Meridian first reported a position in INVA in Q3 2018 and has held it in 12 quarters since. The position peaked at $328K in Q4 2019. 218 funds tracked by Wall St. Rank hold INVA as of Q4 2021.

  • 6 Meridian held 14,286 shares of Innoviva worth $246K as of Q4 2021.
  • 6 Meridian bought 47 Innoviva shares in Q4 2021, an estimated $801.
  • Innoviva made up 0.02% of 6 Meridian's portfolio in Q4 2021, its #265 holding.
  • 6 Meridian first reported a position in Innoviva in Q3 2018 and has held it in 12 quarters since.
  • 6 Meridian's Innoviva position peaked at $328K in Q4 2019.
  • 218 funds tracked by Wall St. Rank held Innoviva as of Q4 2021.

Based on 6 Meridian's 13F filing for Q4 2021, filed 1 Feb 2022.